AlphaYouMU
Insider selling
Marshall Urist sold $722K of Royalty Pharma plc (RPRX) stock
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 13,684 shares of RPRX stock worth $722K, per an SEC Form 4 filed May 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 20, 2026, 2 days before it was made public.
RPRX has moved +10.1% since the trade date, from $53.06 to $58.44 (Sep 21, 2026 close).
- Traded
- May 20, 2026
- Disclosed
- May 22, 2026
- Filing delay
- 2 days
- Price since
- +10.1%
- Role
- EVP, Research & Investments
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.